Expert second opinions for prosthetic valve dysfunction. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Prosthetic Valve Dysfunction h mechanical and bioprosthetic — can develop dysfunction over time. If you are facing a decision about prosthetic valve dysfunction, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Prosthetic heart valves — both mechanical and bioprosthetic — can develop dysfunction over time. Structural valve deterioration (SVD) affects bioprosthetic valves, with most developing significant dysfunction within 10-20 years. Paravalvular leak, pannus formation, and valve thrombosis are other modes of failure.
Management of prosthetic valve dysfunction increasingly includes both surgical and transcatheter options. Valve-in-valve TAVR can treat failed bioprosthetic aortic valves without redo sternotomy. Percutaneous paravalvular leak closure may avoid reoperation. The expanding treatment landscape makes a comprehensive evaluation essential.
Surgery for prosthetic valve dysfunction depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Management of prosthetic valve dysfunction increasingly includes both surgical and transcatheter options. Valve-in-valve TAVR can treat failed bioprosthetic aortic valves without redo sternotomy. Percutaneous paravalvular leak closure may avoid reoperation. The expanding treatment landscape makes a comprehensive evaluation essential.
Operative mortality for prosthetic valve dysfunction-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for prosthetic valve dysfunction depends on anatomy, comorbidities, age, and personal goals. Redo surgery vs valve-in-valve transcatheter approach. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.